JP2025522146A5 - - Google Patents
Info
- Publication number
- JP2025522146A5 JP2025522146A5 JP2025524504A JP2025524504A JP2025522146A5 JP 2025522146 A5 JP2025522146 A5 JP 2025522146A5 JP 2025524504 A JP2025524504 A JP 2025524504A JP 2025524504 A JP2025524504 A JP 2025524504A JP 2025522146 A5 JP2025522146 A5 JP 2025522146A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- approximately
- amount ranging
- present
- alprazolam
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2022/036579 WO2024010592A1 (en) | 2022-07-08 | 2022-07-08 | Pharmaceutical compositions and methods for treating insomnia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025522146A JP2025522146A (ja) | 2025-07-10 |
| JP2025522146A5 true JP2025522146A5 (enExample) | 2025-07-17 |
Family
ID=89453886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025524504A Pending JP2025522146A (ja) | 2022-07-08 | 2022-07-08 | 不眠症を治療するための医薬組成物および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250205218A1 (enExample) |
| EP (1) | EP4551220A4 (enExample) |
| JP (1) | JP2025522146A (enExample) |
| CN (1) | CN119255803A (enExample) |
| AU (1) | AU2022468585A1 (enExample) |
| CA (1) | CA3261198A1 (enExample) |
| WO (1) | WO2024010592A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12370198B2 (en) | 2022-07-08 | 2025-07-29 | La Pharmatech Inc | Pharmaceutical compositions and methods for treating psychiatric disorders |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007524652A (ja) * | 2003-09-26 | 2007-08-30 | アルザ・コーポレーシヨン | アルプラゾラムの制御送達のための浸透性投薬形態物 |
| JP2005179311A (ja) * | 2003-12-24 | 2005-07-07 | Lion Corp | ゼリー状睡眠薬製剤 |
| JP2008143807A (ja) * | 2006-12-07 | 2008-06-26 | Sato Pharmaceutical Co Ltd | 感冒薬カプセル剤及びその製造方法 |
| GB0714713D0 (en) * | 2007-07-27 | 2007-09-05 | Glaxo Group Ltd | Novel compounds |
| ES2403193T3 (es) * | 2008-02-05 | 2013-05-16 | Laboratorios Bago S.A. | Composiciones que comprenden alprazolam para el tratamiento del insomnio primario y del insomnio asociado con estados de ansiedad y procedimientos para su preparación |
| MY177906A (en) * | 2014-02-06 | 2020-09-25 | Sequential Medicine Ltd | Composition and method for aiding sleep |
| FI3787596T3 (fi) * | 2018-05-02 | 2025-09-29 | Ferring Bv | Parannettuja farmaseuttisia formulaatioita |
| US10898493B2 (en) * | 2019-04-12 | 2021-01-26 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for psychiatric symptoms of patients with Alzheimer's disease |
| EP3996697A1 (fr) * | 2019-07-09 | 2022-05-18 | Université de Bretagne Occidentale (U.B.O.) | Nouveaux composés inhibiteurs de la pfar |
-
2022
- 2022-07-08 EP EP22950427.9A patent/EP4551220A4/en active Pending
- 2022-07-08 CA CA3261198A patent/CA3261198A1/en active Pending
- 2022-07-08 JP JP2025524504A patent/JP2025522146A/ja active Pending
- 2022-07-08 WO PCT/US2022/036579 patent/WO2024010592A1/en not_active Ceased
- 2022-07-08 CN CN202280096908.XA patent/CN119255803A/zh active Pending
- 2022-07-08 AU AU2022468585A patent/AU2022468585A1/en active Pending
-
2024
- 2024-11-01 US US18/934,396 patent/US20250205218A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022180461A5 (enExample) | ||
| JP2024074963A5 (enExample) | ||
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| HUE029677T2 (hu) | Készítmények centrálisan mediált émelygés és hányás kezelésére | |
| JP2018507243A5 (enExample) | ||
| JP2024507810A5 (enExample) | ||
| AR045289A1 (es) | Forma de dosificacion oral de liberacion controlada que comprende 4-(2-di-n-propilaminoetil) - 2(3h)-indolona (ropi-nirol) y uso de dicha forma de dosificacion para la elaboracion de un medicamento | |
| JP2023500032A5 (enExample) | ||
| JP2020522560A5 (enExample) | ||
| MX2024006270A (es) | Nueva composicion farmaceutica oral y regimen de dosificacion para la terapia de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| MX2024010637A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JP2023545372A5 (enExample) | ||
| EA202190544A1 (ru) | Применение распадающихся в полости рта таблеток рилузола для лечения заболеваний | |
| JP2023549849A5 (enExample) | ||
| JP2016505050A5 (enExample) | ||
| RU2011111792A (ru) | Применение парацетамола и ибупрофена в лечении | |
| WO2017148129A1 (zh) | 一种用于治疗恶病质的药物组合物及其应用 | |
| JP2025511402A5 (enExample) | ||
| JP2025511401A5 (enExample) | ||
| JP2024531799A5 (enExample) | ||
| JP2024540439A5 (enExample) | ||
| JP2024528731A5 (enExample) | ||
| RU2006139819A (ru) | Применение симетикона для предрасположенных к запорам пациентов | |
| JP2023544249A5 (enExample) | ||
| JP2019535830A5 (enExample) |